SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-16-000534
Filing Date
2016-06-22
Accepted
2016-06-22 10:30:18
Documents
4
Period of Report
2016-06-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ptx_8k.htm 8-K 29228
2 PRESS RELEASE BY PERNIX THERAPEUTICS HOLDINGS, INC. DATED JUNE 16, 2016 ptx_ex991.htm EX-99.1 16503
3 IMAGE ptx_ex991000.jpg GRAPHIC 3527
4 IMAGE ptx_ex991001.jpg GRAPHIC 4616
  Complete submission text file 0001654954-16-000534.txt   58574
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14494 | Film No.: 161725885
SIC: 2834 Pharmaceutical Preparations